tiprankstipranks
Trending News
More News >
Immunoprecise Antibodies Ltd. (IPA)
:IPA

ImmunoPrecise Antibodies (IPA) Revenue

Compare
269 Followers

ImmunoPrecise Antibodies Revenue

ImmunoPrecise Antibodies had a revenue of 6.13M in the quarter ending Dec 31, 2024, with 16.38%. This bring the company's revenue in the last twelve months to 24.07M, Increased -16.38%. In the fiscal year ending Jun 30, 2024, ImmunoPrecise Antibodies had annual revenue of 24.52M with 18.65% growth.
Revenue (ttm)
24.07M
Revenue Growth
-0.71%
P/S Ratio
0.81
Revenue/Employee
$340,528
Employees
72
Market Cap
$19.91M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 202424.52M3.85M+18.65%
Jun 30, 202320.66M1.30M+6.72%
Jun 30, 202219.36M1.45M+8.11%
Jun 30, 202117.91M3.85M+27.42%
Jun 30, 202014.06M3.13M+28.66%
Jun 30, 201910.93M5.48M+100.80%
Jun 30, 20185.44M2.81M+106.85%
Jun 30, 20172.63M734.40K+38.73%
Jun 30, 20161.90M132.53K+7.51%
Dec 31, 20141.76M+∞%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis